Solid Biosciences SLDB
NASDAQ SLDB
$6.85 -0.13 (-1.86%)
At close: Oct 2, 2026 · 4:00 PM EDT

Solid Biosciences (SLDB) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Solid Biosciences (SLDB) reported Return on Capital Employed [ROCE] of -53.96% for Q2 2026, down 1.03 percentage points from -52.94% a year earlier but up 12.09 percentage points from the prior quarter.

Analysis

Solid Biosciences (SLDB) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Solid Biosciences posted Return on Capital Employed [ROCE] of -101.17%, down 12.65 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined for four consecutive years, with a five-year change of -22.83 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -88.53% in FY2024 (-35.89 pp), -52.63% in FY2023 (-5.07 pp), -47.56% in FY2022 (-7.01 pp) and -40.55% in FY2021 (+37.79 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -81.55% in Q4 2025 and a high of -31.91% in Q3 2021.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last seven quarters, with an average year-over-year change of -5.26 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2021 (a gain of 256.38 percentage points); the low point was Q4 2022 (a drop of 19.98 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -66.05% (Q1 2026), -81.55% (Q4 2025) and -66.61% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Solid Biosciences 984.27 Mn 984.27 Mn - -53.96%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -53.96%
Mar 31, 2026 -66.05%
Dec 31, 2025 -81.55%
Sep 30, 2025 -66.61%
Jun 30, 2025 -52.94%
Mar 31, 2025 -60.17%
Dec 31, 2024 -76.32%
Sep 30, 2024 -56.46%
Jun 30, 2024 -44.43%
Mar 31, 2024 -51.48%
Dec 31, 2023 -65.03%
Sep 30, 2023 -65.15%
Jun 30, 2023 -56.92%
Mar 31, 2023 -50.35%
Dec 31, 2022 -53.26%
Sep 30, 2022 -50.42%
Jun 30, 2022 -46.93%
Mar 31, 2022 -40.73%
Dec 31, 2021 -33.28%
Sep 30, 2021 -31.91%
API Access

Solid Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SLDB&period=max&api_key=YOUR_API_KEY